The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.

We use age-structured models for VZV transmission and reactivation to reconstruct the natural history of VZV in Norway based on available pre-vaccination serological data, contact matrices, and herpes zoster incidence data. Depending on the hypotheses on contact and transmission patterns, the basic...

Full description

Bibliographic Details
Main Authors: Luigi Marangi, Grazina Mirinaviciute, Elmira Flem, Gianpaolo Scalia Tomba, Giorgio Guzzetta, Birgitte Freiesleben de Blasio, Piero Manfredi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5436649?pdf=render
id doaj-07cae4fb25a345fc9b58cf8d10249dad
record_format Article
spelling doaj-07cae4fb25a345fc9b58cf8d10249dad2020-11-25T01:48:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01125e017684510.1371/journal.pone.0176845The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Luigi MarangiGrazina MirinaviciuteElmira FlemGianpaolo Scalia TombaGiorgio GuzzettaBirgitte Freiesleben de BlasioPiero ManfrediWe use age-structured models for VZV transmission and reactivation to reconstruct the natural history of VZV in Norway based on available pre-vaccination serological data, contact matrices, and herpes zoster incidence data. Depending on the hypotheses on contact and transmission patterns, the basic reproduction number of varicella in Norway ranges between 3.7 and 5.0, implying a vaccine coverage between 73 and 80% to effectively interrupt transmission with a 100% vaccine efficacy against infection. The varicella force of infection peaks during early childhood (3-5 yrs) and shows a prolonged phase of higher risk during the childbearing period, though quantitative variations can occur depending on contact patterns. By expressing the magnitude of exogenous boosting as a proportion of the force of infection, it is shown that reactivation is well described by a progressive immunity mechanism sustained by a large, though possibly below 100%, degree of exogenous boosting, in agreement with findings from other Nordic countries, implying large reproduction numbers of boosting. Moreover, magnitudes of exogenous boosting below 40% are robustly disconfirmed by data. These results bring further insight on the magnitude of immunity boosting and its relationship with reactivation.http://europepmc.org/articles/PMC5436649?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Luigi Marangi
Grazina Mirinaviciute
Elmira Flem
Gianpaolo Scalia Tomba
Giorgio Guzzetta
Birgitte Freiesleben de Blasio
Piero Manfredi
spellingShingle Luigi Marangi
Grazina Mirinaviciute
Elmira Flem
Gianpaolo Scalia Tomba
Giorgio Guzzetta
Birgitte Freiesleben de Blasio
Piero Manfredi
The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
PLoS ONE
author_facet Luigi Marangi
Grazina Mirinaviciute
Elmira Flem
Gianpaolo Scalia Tomba
Giorgio Guzzetta
Birgitte Freiesleben de Blasio
Piero Manfredi
author_sort Luigi Marangi
title The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
title_short The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
title_full The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
title_fullStr The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
title_full_unstemmed The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
title_sort natural history of varicella zoster virus infection in norway: further insights on exogenous boosting and progressive immunity to herpes zoster.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description We use age-structured models for VZV transmission and reactivation to reconstruct the natural history of VZV in Norway based on available pre-vaccination serological data, contact matrices, and herpes zoster incidence data. Depending on the hypotheses on contact and transmission patterns, the basic reproduction number of varicella in Norway ranges between 3.7 and 5.0, implying a vaccine coverage between 73 and 80% to effectively interrupt transmission with a 100% vaccine efficacy against infection. The varicella force of infection peaks during early childhood (3-5 yrs) and shows a prolonged phase of higher risk during the childbearing period, though quantitative variations can occur depending on contact patterns. By expressing the magnitude of exogenous boosting as a proportion of the force of infection, it is shown that reactivation is well described by a progressive immunity mechanism sustained by a large, though possibly below 100%, degree of exogenous boosting, in agreement with findings from other Nordic countries, implying large reproduction numbers of boosting. Moreover, magnitudes of exogenous boosting below 40% are robustly disconfirmed by data. These results bring further insight on the magnitude of immunity boosting and its relationship with reactivation.
url http://europepmc.org/articles/PMC5436649?pdf=render
work_keys_str_mv AT luigimarangi thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT grazinamirinaviciute thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT elmiraflem thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT gianpaoloscaliatomba thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT giorgioguzzetta thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT birgittefreieslebendeblasio thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT pieromanfredi thenaturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT luigimarangi naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT grazinamirinaviciute naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT elmiraflem naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT gianpaoloscaliatomba naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT giorgioguzzetta naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT birgittefreieslebendeblasio naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
AT pieromanfredi naturalhistoryofvaricellazostervirusinfectioninnorwayfurtherinsightsonexogenousboostingandprogressiveimmunitytoherpeszoster
_version_ 1725013176130469888